SCHEMBL20176449

SCHEMBL20176449

CC1(C)c2ccccc2-c2ccc(-c3c4ccccc4c(-c4ccc(B5OC(C)(C)C(C)(C)O5)nc4)c4ccccc34)cc21

nearest known ligand 0.33

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
LPL P06858 2/20 0.33
LIPG Q9Y5X9 2/20 0.33
DGAT1 O75907 1/20 0.32
PDGFRB P09619 1/20 0.31
KDR P35968 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20176824 0.91 LPL (0.33) LPLLIPGDGAT1PDGFRBKDR
SCHEMBL26626355 0.90 LPL (0.37) LPLLIPGDGAT1PDGFRBKDR
SCHEMBL30601312 0.90 LPL (0.37) LPLLIPGDGAT1PDGFRBKDR
SCHEMBL30601279 0.90 LPL (0.37) LPLLIPGDGAT1PDGFRBKDR
SCHEMBL26161352 0.87 LPL (0.33) LPLLIPGDGAT1PDGFRBKDR
SCHEMBL26161356 0.86
SCHEMBL17068921 0.83 LPL (0.37) LPLLIPG
SCHEMBL20176691 0.82
SCHEMBL20176454 0.82 LPL (0.38) LPLLIPGDGAT1PDGFRBKDR
SCHEMBL26161355 0.82

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11667622-B2 Organic light emitting compound and organic electroluminescence device using same SOLUS ADVANCED MATERIALS CO., LTD. (KR) 2023-06-06 US disclosed
US-11667622-B2 Organic light emitting compound and organic electroluminescence device using same SOLUS ADVANCED MATERIALS CO., LTD. (KR) 2023-06-06 US disclosed
WO-2018093231-A1 ORGANIC LIGHT EMITTING COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING SAME 주식회사 두산 2018-05-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11667622-B2 Organic light emitting compound and organic electroluminescence device using same OR10J3, ICMT, SLCO4C1 LPL 695/4885LIPG 812/4885DGAT1 281/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.